04

May2015

PDCI International Trends Series

In preparation for the recent Pharma Symposium conference held in Toronto on March 31-April 1, PDCI conducted an online survey of a select group of pharmaceutical stakeholders in Canada and Europe.  The purpose of this survey was to gauge whether some of the cost containment mechanisms being implemented in certain ... Read More

10

Apr2015

Updates to the Manufacturer Submission Requirements in the Alberta Drug Benefit List (ADBL)

Please be advised that updates to the Manufacturer Submission Policy were published effective April 1, 2015 and can be found at: https://idbl.ab.bluecross.ca/idbl/PDFS/dbl_sec1_drug.pdf Should Manufacturers require additional clarification regarding the published Manufacturer Submission Policy please contact Alberta Blue Cross, Scientific and Research Services at: submissions@ab.bluecross.ca For more information, please see ... Read More

30

Mar2015

Rare Diseases Campaign

We recently participated in Mediaplanet Canada’s Rare Diseases campaign in which many industry leaders united to provide Canadians with a comprehensive view of Canada’s healthcare system and the policies that affect the lives of those living with or affected by rare disorders. The campaign was distributed through the National Post on ... Read More

14

Jan2015

Drug products undergoing evaluation for the June 2015 “Liste des médicaments”

QUEBEC L’Institut national d’excellence en santé et en services sociaux (INESSS) has released the list of drug products submitted for the June 2015 “Liste des médicaments.” Health professionals, citizens and patients and their associations and groups have until ... Read More

06

Nov2014

Proposed Regulation Amendments to Establish a Pricing Framework for Generic Products

ONTARIO Proposed Regulation Amendments to Establish a Pricing Framework for Generic Products An Ontario Public Drug Programs Executive Officer Communication published on November 5, 2014 invites stakeholder comments on proposed amendments to O. Reg. 201/96 under the Ontario Drug Benefit Act. The proposed amendments would establish a pricing framework for ... Read More

22

Oct2014

Meetings with Manufacturers for the June 2015 “Liste des médicaments”

QUEBEC Meetings with Manufacturers for the June 2015 “Liste des médicaments” As part of the June 2015 updates to the “Liste des medicaments,” INESSS will meet with manufacturers who have made submissions before the deadline. These meetings with take place between December 15-19, 2014 and January 5-9, 2015 inclusively and will cover: Discussions on ... Read More

02

Oct2014

QUEBEC: October Update for the “Liste des médicaments”

The Régie de l’assurance maladie du Québec (RAMQ) has released its October update of the List of Medications, which constitutes a regulatory list of the medications covered by Québec's basic prescription drug insurance plan. For more information and to see the list update schedule, please visit the RAMQ website.

29

Jul2014

New Brunswick: Rare diseases drug plan established

New Brunswick is the latest Canadian province to establish a specialized drug plan to fund high cost drugs for certain rare diseases. Starting August 1,2014, the planwill begin accepting applications to cover the cost of five drugs for the following specific rare diseases: Aldurazyme for the treatment of Hurler and Hurler-Scheie ... Read More

08

Jul2014

QUEBEC: INESSS to have meetings with manufacturers for February 2015 Liste des médicaments update

The Institut national d’excellence en santé et en services sociaux will have meetings with manufacturers who have submitted applications in advance of the deadline for the February 2015 Liste des médicaments update. Discussions will address clinical studies and economic and pharmacoeconomic aspects ... Read More

16

Jun2014

QUEBEC: Submission deadlines published

The Ministry of Health and Social Services has authorized the Institut National d’excellence en santé et en services sociaux (INESSS) (National Institute for Excellence in Health and Social Services) to issue 7 updates in 2015 to the Liste de médicaments.  Updates will occur in February, March, April, June, July, October ... Read More